Elm3 Financial Group LLC Buys Shares of 3,752 VanEck Pharmaceutical ETF (NASDAQ:PPH)

Elm3 Financial Group LLC purchased a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 3,752 shares of the company’s stock, valued at approximately $324,000. Elm3 Financial Group LLC owned 0.06% of VanEck Pharmaceutical ETF as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. FMR LLC lifted its position in shares of VanEck Pharmaceutical ETF by 12.5% during the third quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after acquiring an additional 212 shares in the last quarter. Edge Financial Advisors LLC purchased a new stake in VanEck Pharmaceutical ETF during the 3rd quarter worth about $263,000. Grimes & Company Inc. bought a new position in VanEck Pharmaceutical ETF in the 4th quarter worth about $310,000. Harbour Investments Inc. boosted its stake in VanEck Pharmaceutical ETF by 16.6% in the 3rd quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after purchasing an additional 488 shares during the period. Finally, Townsquare Capital LLC grew its holdings in VanEck Pharmaceutical ETF by 3.8% during the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after buying an additional 130 shares in the last quarter.

VanEck Pharmaceutical ETF Trading Up 1.9 %

Shares of VanEck Pharmaceutical ETF stock opened at $90.11 on Thursday. VanEck Pharmaceutical ETF has a 12-month low of $84.48 and a 12-month high of $99.51. The company has a market cap of $557.78 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. The company’s 50-day moving average price is $87.78 and its 200-day moving average price is $91.76.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently declared a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were issued a $0.411 dividend. The ex-dividend date of this dividend was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.